Dr. Jorge J Castillo | CureTalks
Jorge J. Castillo, MD is the Clinical Director at Bing Center for Waldenström Macroglobulinemia. He is the Senior Physician and an Associate Professor of Medicine at Harvard Medical School. He is currently the principal investigator in a series of clinical trials evaluating highly effective non-chemotherapeutic approaches. He has served as an Assistant Professor of Medicine at Brown University for 5 years. His clinical practice and research interests at the Dana-Farber Cancer Institute focuses on patients with Waldenstrom Macroglobulinemia. He received his medical degree at the Universidad Autonoma Metropolitana, Mexico City and his Residency from Metrowest Medical Center, Internal Medicine. He has completed his Hematology and Oncology training at Brown University.
Diagnosis and Management of Waldenstrom’s Macroglobulinemia
Waldenstrom's macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein…